Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
|
Mid-range Performer
1119.2000
-9.70
(
-0.86
%)
NSE
Sep 19, 2025
15:31 PM
27.36% Fall from 52W High
Volume:
959.0K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
13 Aug 2020
1119.20
-0.86%
Aurobindo Pharma (BUY): In-line Q1; earnings, balance sheet comfort merit higher multiple
Buy:
Aurobindo Pharma Ltd.
by
BOB Capital Markets Ltd.
Target: 1000
Target
BOB Capital Markets Ltd.
Q1 revenue/EBITDA were in line backed by strong US sales and sustained gross margins.
Aurobindo Pharma Ltd. is trading
below its 100 day SMA
of 1126.0
More from Aurobindo Pharma Ltd.
Recommended
Five Interesting Stocks Today - September 19, 2025
The Baseline |
19 Sep 2025, 04:31PM
Market closes lower, JSW Energy arm to acquire Tidong Power
Trendlyne Marketwatch |
19 Sep 2025, 03:58PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020